Ruby Singhrao - Univ Calif San Francisco, San Francisco, CA 94143 USA

基本信息

浏览量：5

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 33 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Evaluation of Navify Mutation Profiler Tertiary Analysis Software Assessing for Hematologic Malignancies

Ruby Singhrao, Michael J. Clark, Shikha Chugh, Lisha Capucion, Shuba Krishna, Ranga Yerram, Lili Niu, Adama Parham, Amy Harrell, John Duncan, Kristina Clark, Manana Javey

Journal of Molecular Pathology (2025)

引用0浏览0引用

Neoadjuvant Trebananib Plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery

CLINICAL CANCER RESEARCHno. 4 (2024): 729-740

引用6浏览0WOS引用

Supplementary Figure S1 from Neoadjuvant Trebananib Plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

openalex（2024）

引用0浏览0引用

Supplementary Table S3 from Neoadjuvant Trebananib Plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

openalex（2024）

引用0浏览0引用

Supplementary Table S1 from Neoadjuvant Trebananib Plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

openalex（2024）

引用0浏览0引用

Supplementary Table S4 from Neoadjuvant Trebananib Plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

openalex（2024）

引用0浏览0引用

Early Noninvasive Tracking of Response to Targeted Therapy in Non-Small Cell Lung Cancer

Hatim Husain,Kevin Lu,Brian Woodward,Ruby Singhrao, Manana Javey,Hans-Peter Adams, Ulrich Schlecht, Zhipei Gracie Du,David Morgenstern

crossref（2024）

引用0浏览0引用

Pexidartinib and Standard Neoadjuvant Therapy in the Adaptively Randomized I-SPY2 Trial for Early Breast Cancer

Breast Cancer Research and Treatmentpp.1-6, (2024)

引用0浏览0WOS引用

Supplementary Methods S1 from Neoadjuvant Trebananib Plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

openalex（2024）

引用0浏览0引用

Clinical Evaluation of Somatic Genomic Alteration Annotation for Hematological Malignancies Using Tertiary Analysis Software

Ruby Singhrao,Lisha Capucion, Shikha Chugh,Shuba Krishna, Adama Parham,Amy Harrell,Ranga Yerram, John Duncan, Manana Javey

Cancer Researchno. 12_Supplement (2022): 5236-5236

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn